Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy. [electronic resource]
Producer: 20100128Description: 802-11 p. digitalISSN:- 2092-6413
- Animals
- Aorta -- metabolism
- Cell Proliferation -- drug effects
- Cyclooxygenase 2 -- metabolism
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetic Angiopathies -- drug therapy
- Glycation End Products, Advanced -- metabolism
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Male
- Myocytes, Smooth Muscle -- metabolism
- Oxidative Stress -- drug effects
- Proto-Oncogene Proteins c-jun -- metabolism
- Rats
- Rats, Sprague-Dawley
- Reactive Oxygen Species -- metabolism
- Signal Transduction -- drug effects
- Simvastatin -- pharmacology
- Transcription Factor RelA -- metabolism
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.